|
Market Closed -
NYSE
23:00:00 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.640 USD | -3.30% |
|
-1.12% | +46.67% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
|
Boerse Muenchen
| PBDA | Real-time | |
|
Tradegate
| PBDA | Real-time | |
|
Börse Stuttgart
| PBDA | Delayed | |
|
Deutsche Boerse AG
| PBDA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 2.73 | 2.87 | 3.06 |
| Spread/Res. | -3.30% | -8.01% | -13.73% |
| Spread/Supp. | +8.64% | +38.95% | +52.60% |
| Support | 2.43 | 1.9 | 1.73 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PLX Stock
- Charts Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
